Nanoviricides Inc (NNVC)

$1.13 0.07 (5.83%)

20:00 EDT NNVC Stock Quote Delayed 30 Minutes

3 Nanotech Stocks With the Potential to Make You an Overnight Millionaire

By Matthew Farley, InvestorPlace Contributor May 2, 2024

Discover three nanotech stocks poised for explosive growth in a booming market. Explore their potential for massive returns.

The 7 Most Promising Penny Stocks to Buy in June

7 Speculative Penny Stocks Under $3 That Deserve Your Attention in Nov.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

More Articles

Volume:

Previous Close -

Market Cap 13.31M

PE Ratio -1.40

EPS -0.81

Volume (Avg. Vol.) 26,413

Day's Range $1.10 - $1.17

52-Week Range $1.00 - $2.00

Dividend & Yield N/A (N/A)

NNVC Stock Predictions, Articles, and Nanoviricides Inc News

From InvestorPlace
From the Web

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Nov 15, 2021

Welcome back, trader! We're getting right into the thick of it this week with a look at the biggest pre-market stock movers for Monday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Sep 27, 2021

Welcome back, investor! We're starting off the week with a dive into the biggest pre-market stock movers for Monday morning!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Sep 23, 2021

Good morning, investor! We're diving back into the stock market again today with a look at the biggest pre-market stock movers for Thursday!

NNVC Stock: What Is Going on With Red-Hot NanoViricides Today?

By Samuel O'Brient, InvestorPlace Reporter Sep 21, 2021

A Covid-19 treatment producer halted trading this morning, but news has revealed that NNVC stock is still moving upward.

What Is a ‘News Pending’ Halt? What to Know as NNVC Stock Captivates Investors

By Chris MacDonald, InvestorPlace Contributor Sep 21, 2021

Today, NanoViricides is grabbing a lot of attention due to a news pending halt that has sent NNVC stock skyrocketing.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Sep 21, 2021

Good morning, trader! Another busy day of trading is already underway as we look at the biggest pre-market stock movers for Tuesday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Sep 15, 2021

Good morning, investor! We're jumping back into the stock market as we take a look at the biggest pre-market stock movers for Wednesday.

What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.

By Sarah Smith, Editor-in-Chief, InvestorPlace.com Mar 2, 2021

What did the stock market do today? Investors focused on a social media ETF, cannabis stocks and the damages of the 2021 chip shortage.

NNVC Stock: The COVID-19 Drug News That Has NanoViricides Rocketing Today

By William White, InvestorPlace Writer Mar 2, 2021

NanoViricides (NNVC) stock is on the rise Tuesday after revealing results from the company's drug candidates to treat the coronavirus.

3 Nanotech Stocks for Big Growth

By Ian Cooper, InvestorPlace Contributor Jun 4, 2020

The global nanotechnology market could exceed $125 billion by 2024, as it continues to impact technology, energy, defense, and even food.

Stock Market Today: Coronavirus Stokes Fear; Uber Stock Rallies

By Bret Kenwell, InvestorPlace Contributor Jan 21, 2020

Boeing shares tanked on more negative reports, while Uber rallied on an asset sale. Here's what happened in the stock market today.

NanoViricides reports positive safety results for COVID drug candidate (NYSE:NNVC)

From Seeking Alpha Jan 29, 2024

NanoViricides (NNVC) has reported positive Phase 1 safety data for its antiviral drug NV-CoV-2 for the treatment of COVID and RSV. Read more here.

NanoViricides Patents Its Antiviral Nanotechnology for COVID-19, Continuing Its Development of Potentially Broad-Spectrum Drugs That Are Expected To Be Effective Even Against Emerging Variants

From Benzinga May 25, 2022

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

58 Biggest Movers From Yesterday

From Benzinga May 24, 2022

Gainers Catalyst Biosciences, Inc. (NASDAQ: CBIO) gained 234.2% to close at $1.27 after the company announced it sold its complement portfolio for $60 million.

NanoViricides Starts Drug Development Program For Recent Cases Of Unexplained Pediatric Hepatitis

From Benzinga May 16, 2022

30 Stocks Moving In Monday's Mid-Day Session

From Benzinga May 23, 2022

Gainers Evolve Transition Infrastructure LP (NYSE: SNMP) shares rose 29.2% to $0.6699 after jumping around 14% on Friday.

Mid-Morning Market Update: Markets Mixed; Broadcom In Talks To Buy VMWare

From Benzinga May 23, 2022

U.S. stocks traded mixed this morning, with the Dow Jones gaining around 250 points on Monday.

ADVERTISEMENT